Breast Surgeons Live
Back to Activities List
Session Title:
Adolescents and Young Adults Facing Breast Cancer
Date & Time:
November 11, 2025, 7:00 PM–8:00 PM ET
Length:
1 Hour
CME Deadline:
November 11, 2026
This activity is open to members only:
Log InTarget Audience:
Surgeons with a special interest in the treatment of breast disease.
Objectives:
coming soon
Description:
There has been an increased incidence in breast cancer in adolescents and young adults (AYA) over the past decade. This young population faces additional challenges and considerations in relation to their long-term health, fertility / pregnancy, and quality of life. This session will review the current and evolving data on fertility preservation and interrupting endocrine therapy to facilitate pregnancy and additional unique considerations in AYA with breast cancer.
Agenda:
Welcome and Introduction
Sara Myers MD, FACS, and Rachel Greenup, MD, MPH, FACS
Challenges and Considerations for Fertility Preservation
Ellie Proussaloglou, MD
Endocrine Therapy and Pregnancy
Mediget Teshome, MD, FACS
Faculty:
Moderator—Sara Myers, MD, PhD FACS
The Ohio State University Wexner Medical Center
Columbus, OH
Moderator—Rachel Greenup, MD, MPH, FACS
Yale School of Medicine
New Haven, CT
Ellie Proussaloglou, MD
Yale University
New Haven, CT
Mediget Teshome, MD, MPH, FACS
UCLA Health Jonsson Comprehensive Cancer Center/DGSOM
Los Angeles, CA
References:
- Hours A, Toussaint A, De Castelbajac V, Sautter C, Borghese J, Frank S, Coussy F, Laas E, Grandal B, Dumas E, Daoud E, Guerin J, Balezeau T, Feron JG, Fourchotte V, Kirova Y, Lerebours F, Pierga JY, Guillot E, Santulli P, Grynberg M, Sonigo C, Reyrat E, Soibinet-Oudot P, Reyal F, Hamy AS. Factors Associated With the Discussion of Fertility Preservation in a Cohort of 1,357 Young Breast Cancer Patients Receiving Chemotherapy. Front Oncol. 2021 Sep 28;11:701620. doi: 10.3389/fonc.2021.701620. PMID: 34650912; PMCID: PMC8507557.
- Marklund A, Lundberg FE, Eloranta S, Hedayati E, Pettersson K, Rodriguez-Wallberg KA. Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation. JAMA Oncol. 2021 Jan 1;7(1):86-91. doi: 10.1001/jamaoncol.2020.5957. PMID: 33211089; PMCID: PMC7677871.
- Letourneau JM, Wald K, Sinha N, Juarez-Hernandez F, Harris E, Cedars MI, McCulloch CE, Dolezal M, Chien AJ, Rosen MP. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation. Cancer. 2020 Feb 1;126(3):487-495. doi: 10.1002/cncr.32546. Epub 2019 Oct 22. PMID: 31639215.
- Sella T, Poorvu PD, Ruddy KJ, Gelber SI, Tamimi RM, Peppercorn JM, Schapira L, Borges VF, Come SE, Partridge AH, Rosenberg SM. Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors. Cancer. 2021 Aug 15;127(16):2888-2894. doi: 10.1002/cncr.33596. Epub 2021 Apr 22. PMID: 33886123; PMCID: PMC8351455.
- Murphy BL, Pereslucha A, Boughey JC. Current Considerations in Surgical Treatment for Adolescents and Young Women with Breast Cancer. Healthcare (Basel). 2022 Dec 15;10(12):2542. doi: 10.3390/healthcare10122542. PMID: 36554065; PMCID: PMC9777860.
Disclosures:
coming soon
